MedWatch

New EU directive to require enormous cybersecurity investments

An upcoming revision of the EU's cybersecurity directive NIS2 heralds more rules for the security of network and information systems and company reporting across industries. However, experience shows that estimates might be too low, says the Danish Chamber of Commerce.

Photo: Thomas Borberg

Cybersecurity requirements, which are being debated in Brussels these months, could herald markedly higher encryption and cybersecurity expenses for many firms, including those in the life sciences industry, as evident in the European Commission's impact assessment of its revised cybersecurity directive proposal, the NIS2.

Were it only up to the Commission and members of the European Parliament, more companies – including, for instance, drugmakers – would face new rules pertaining to encryption and the reporting of cyberattacks, and more.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs